Health, Fitness & Food

Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a trial over the safety of its formula for premature babies. The news Abbott Labs’ specialized formula is not responsible for a young baby boy developing a severe intestinal illness known as necrotizing enterocolitis, or NEC, a jury in Missouri
0 Comments
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.
0 Comments
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023.  Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street’s expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images All doses of Novo Nordisk‘s highly popular weight loss injection Wegovy and diabetes drug Ozempic are now
0 Comments
In this article MCD Follow your favorite stocksCREATE FREE ACCOUNT McDonald’s Chris Kempczinski speaks about fresh beef expansion at a McDonald’s event in Oak Brook, Illinois. Richa Naidu | Reuters A week after health authorities publicly linked a deadly E. coli outbreak to McDonald’s Quarter Pounder burgers, the company’s CEO, Chris Kempczinski, told investors that
0 Comments
Larry Ellison, chairman and co-founder of Oracle Corp., speaks during the Oracle OpenWorld 2017 conference in San Francisco, California, U.S., on Sunday, Oct. 1, 2017. David Paul Morris | Bloomberg | Getty Images Oracle on Monday announced it intends to join a new federally-backed medical network that will make it easier for clinics, hospitals and
0 Comments
In this article MCD Follow your favorite stocksCREATE FREE ACCOUNT A double quarter pounder with cheese and fries arranged at a McDonald’s restaurant in El Sobrante, California, US, on Wednesday, Oct. 23, 2024.  David Paul Morris | Bloomberg | Getty Images McDonald’s Quarter Pounder burgers will return to roughly 900 restaurants this week after the
0 Comments
Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq after all of its independent board members resigned in September. So what happened? Founded in 2006, 23andMe set out to revolutionize the once very exclusive genetic testing business with a direct-to-consumer model. Thanks
0 Comments
In this article DXCM Follow your favorite stocksCREATE FREE ACCOUNT Kevin Sayer, CEO, Dexcom Scott Mlyn | CNBC Shares of Dexcom fell 9% in extended trading on Thursday after the company released third-quarter results that beat analysts’ expectations but showed a decline in U.S. revenue year over year. Here’s how the company did: Earnings per
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday.  Semaglutide, the active ingredient in
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection
0 Comments
Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter. Danaher’s revenue for the three months ended Sept. 27 advanced 3% year over year on a reported basis, to $5.8 billion, outpacing the LSEG consensus estimate of $5.59 billion. On an organic basis, sales were
0 Comments